CL.CN Q2 2026: Cresco Labs Hits 23% EBITDA, 23% Revenue Growth Despite Market Pressure
Read how Cresco Labs’ Q2 2026 earnings beat expectations with 23% revenue growth and a 23% adjusted EBITDA margin, yet the stock remains pressured by market volatility.
3 minutes to read